Evidence map›Paper›PMID 31722160›Full record

ArticleThe New England journal of medicine2019

10-Year Update on Study Results Submitted to ClinicalTrials.gov.

Deborah A Zarin, Kevin M Fain, Heather D Dobbins, Tony Tse, Rebecca J Williams

Abstract read
In one paragraph

Article in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Frontiers in cell and developmental biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Interpretation and Examples: Key Updates in SPIRIT 2025 Statement].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deborah A ZarinFrom the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD.
Kevin M FainFrom the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD.
Heather D DobbinsFrom the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD.
Tony TseFrom the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD.
Rebecca J WilliamsFrom the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD.

Funding

ClinicalTrial Registration and Results ReportingZ01LM008926 · NLM · NATIONAL LIBRARY OF MEDICINE · PI ZARIN, DEBORAH · 2008 to 2008
$938k
Intramural NIH HHS Z01 LM008926
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Databases, FactualGovernment RegulationRegistriesClinical Trials as TopicFollow-Up StudiesHealth PolicyHumansNational Institutes of Health (U.S.)Quality ControlUnited StatesUnited States Department of Veterans AffairsUnited States Food and Drug Administration

Identifiers

PMID31722160
PMCPMC8591666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.